Silver Book Fact

Between 2008 and 2009, the number of Americans age 65-74 who reported trouble seeing (even with glasses or contacts) decreased from 14.3% to 10.3%.  The number of Americans age 75 and older who reported trouble seeing also decreased during that time period–from 21.1% to 16.5%.

National Center for Health Statistics. Health: United States, 2010: With special feature on death and dying. Atlanta, GA: Centers for Disease Control and Prevention; 2010. http://www.cdc.gov/nchs/data/hus/hus10.pdf

Reference

Title
Health: United States, 2010: With special feature on death and dying
Publisher
Centers for Disease Control and Prevention
Publication Date
2010
Authors
National Center for Health Statistics
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Macugen to treat wet age-related macular degeneration (AMD)
    A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.  
  • Treatment costs for a patient with early-stage glaucoma are about $2,000 less than those of a patient diagnosed with a later stage of the disease.  
  • After 9 years of tight blood pressure control, patients with type 2 diabetes had a 34% reduction in retinopathy progression and a 47% reduction in risk of visual acuity deterioration…  
  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.  
  • Supplementation with lutein increases macular pigment optical density by 27%; which is correlated with benefits in visual function.